Clinical Trial Update: A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis [Phase 3]

View source ↗

Summary

This update describes a Phase 3 clinical trial evaluating intravenous L-Citrulline in patients aged 6-21 with sickle cell disease presenting to emergency depart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Asklepion Pharmaceuticals, LLC | Conditions: Sickle Cell Disease | Phase 3 | Status: NOT_YET_RECRUITING